Home | Business News | Browse by Publication | F | FDA Consumer

The FDA approves drugs for colorectal cancer, lung cancer.

Publication: FDA Consumer
Publication Date: 01-JAN-07
Format: Online
Delivery: Immediate Online Access
Full Article Title: The FDA approves drugs for colorectal cancer, lung cancer.(Updates)

Article Excerpt
The FDA has approved Vectibix (panitumumab) to treat people with colorectal cancer that has spread to other parts of the body (metastasized) after standard chemotherapy. Vectibix, a monoclonal antibody that binds to a protein called epidermal growth factor receptor (EGFR) on some cancer cells, received an accelerated approval after showing effectiveness in slowing tumor growth and, in some cases, reducing the size of the tumor.

In the...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
New hepatitis B treatment.(Updates), January 01, 2007
Cancer drugs: weighing the risks and benefits.(Cover story), January 01, 2007
Study: half of people at high risk unaware they need a flu shot., January 01, 2007
The FDA takes action against unapproved drugs., January 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.